Oncotelic closes initial 11 units of up to 500-unit offering with 12% notes and warrants

Oncotelic Therapeutics, Inc.

Initial closing of 11 units at $25,000 each in best-efforts offering of up to 500 units.
Each unit includes a $25,000 note bearing 12% annual interest, due 2 years after final closing.
Notes convertible into OTLC common at $0.10/share or EdgePoint AI common at $1.00/share.
Each unit includes 250,000 warrants to buy OTLC common at $0.12/share or 25,000 EdgePoint warrants at $1.25/share.
Minimum of 10 units required; funds held in escrow until minimum met; offering exempt under Reg D Rule 506.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.95

Oncotelic Therapeutics, Inc. issued Each Unit consists of one note in the principal amount of $25,000, convertible into up to 250,000 shares of Common Stock or 25,000 shares of EdgePoint Common St of unit to accredited investors for $25,000 per Unit, or exchange of 2023 PPM Note.

Security: unit
Shares: Each Unit consists of one note in the principal amount of $25,000, convertible into up to 250,000 shares of Common Stock or 25,000 shares of EdgePoint Common St
Purchaser: accredited investors
Consideration: $25,000 per Unit, or exchange of 2023 PPM Note

Exact text from the filing

On December 4, 2025, Oncotelic Therapeutics, Inc. (the “ Company ”) completed entering into subscription agreements with certain accredited investors (“ Subscription Agreement ”), whereby the Company issued a total of 11 units (“ Units ”).

View on SEC.gov

Browse all equity issuances →

Oncotelic Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-026883

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.